Novo Holdings A/S 13D and 13G filings for IO Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-17 9:01 pm Sale |
2024-09-13 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 5,823,584 8.500% |
-1,075,000 (-15.58%) |
Filing |
| 2024-05-14 9:35 pm Sale |
2024-05-10 | 13G | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 6,898,584 10.100% |
-658,809 (-8.72%) |
Filing |
| 2024-02-13 9:34 pm Sale |
2024-02-09 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 7,557,393 11.100% |
-658,809 (-8.02%) |
Filing |
| 2023-08-11 4:40 pm Purchase |
2023-08-09 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 8,216,202 12.000% |
4,938,270 (+150.65%) |
Filing |
| 2022-09-30 4:51 pm Unchanged |
2022-09-27 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 3,277,932 11.400% |
0 (Unchanged) |
Filing |
| 2022-05-26 11:57 am Unchanged |
2022-05-25 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 3,277,932 11.300% |
0 (Unchanged) |
Filing |
| 2021-11-10 4:43 pm Purchase |
2021-11-04 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 3,277,932 11.800% |
3,277,932 (New Position) |
Filing |